Founded in 2002, Novartis Institutes for Biomedical Research (NIBR) is a noncommercial research organization within Novartis. Its core mission is to drive drug discovery and early development by uncovering insights into the origins and pathogenesis of diseases. NIBR focuses on delivering transformative medicines to combat disease, restore possibilities, and improve quality of life. The organization operates across various disease areas, leveraging cutting-edge research and development to maintain an industry-leading pipeline of innovative treatments.
NIBR is affiliated with notable researchers and scientists who contribute to its pioneering work in biomedical research. It has achieved significant milestones in drug discovery and development, contributing to the broader impact of Novartis in the pharmaceutical industry. Through its relentless focus on innovation and scientific excellence, NIBR has made substantial contributions to advancing medical science and improving patient outcomes worldwide.
